Shukra Pharmaceuticals Ltd Quarterly Results
Q4 FY25-26 Results Summary
Revenue
The revenue stands at ₹6.32 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 83.85 per cent from ₹39.13 crore. This corresponds to a year-on-year *(YoY) decline of 52.37 per cent.
Operating Profit
Operating Profit stands at ₹0.70 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 97.42 per cent from ₹27.13 crore. This corresponds to a year-on-year *(YoY) decline of 90.44 per cent.
PBDT
PBDT stands at ₹1.39 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 94.97 per cent from ₹27.66 crore. This corresponds to a year-on-year *(YoY) decline of 83.67 per cent.
Profit Before Tax
Profit Before Tax stands at ₹0.38 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 98.58 per cent from ₹26.82 crore. This corresponds to a year-on-year *(YoY) decline of 94.98 per cent.
Net Profit
Net Profit stands at ₹-1.72 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 108.45 per cent from ₹20.36 crore. This represents a 131.91 per cent year-on-year *(YoY) decline for the same year.
- YoY compares a quarter to the same period last year, and QoQ compares it to the previous quarter.
Market News
Shukra Pharmaceuticals Ltd Earnings
- YOY
- QOQ
Shukra Pharmaceuticals Ltd Earning Charts
Revenue from Operations
in ₹ cr
EBITDA
in ₹ cr
Profit before Tax
in ₹ cr
Net Profit
in ₹ cr
Shukra Pharmaceuticals Ltd Research Reports
| Action | Target Price (₹) | Broker | Date | Reports |
|---|---|---|---|---|
| Data Not Found | ||||
Shukra Pharmaceuticals Ltd Financial Reports
Shukra Pharmaceuticals Ltd Stock Prices Compare with Peers
| Company | 1 Day | 1 Week | 1 month | 3 month | 6 month | 1 Year |
|---|---|---|---|---|---|---|
| Shukra Pharma. | -0.71% | 1.16% | 11.77% | -3.36% | -31.45% | 58.34% |
| Windlas Biotech | -0.93% | 0.27% | 1.53% | -3.85% | -2.05% | -10.92% |
| Fredun Pharma | -65.08% | 14.61% | 13.44% | 60.99% | 95.42% | 213.46% |
| Amrutanjan Healt | 0.36% | -0.98% | -0.16% | -2.00% | -12.20% | -23.53% |
| Jagsonpal Pharma | 0.58% | -3.56% | 7.35% | 17.04% | 29.09% | -10.80% |
| Fermenta Biotec. | -0.53% | 10.86% | 41.86% | 46.01% | 34.82% | 23.07% |
| Syncom Formul. | -0.43% | -2.89% | -3.10% | -3.97% | 8.77% | -26.72% |
Company Info
Company Information
Chairman / Executive Director / Managing Director : Dakshesh Shah
Executive Director : Payal Mehta
E D & Wholetime Director : Dhruvin Shah
E D & Wholetime Director : Sanskruti Patel
Independent Non Exe. Director : Pinki Nirmal Sagar
Independent Non Exe. Director : Sonal Deepalbhai Gandhi
Independent Non Exe. Director : Sarjeevan Singh
Independent Non Exe. Director : Jitendra shah
Executive Director / Whole Time Director / CFO : Anar Jayesh Patel
E D & Wholetime Director : SHITAL DAKSHESH SHAH
Independent Non Exe. Director : Ritu Kapoor
Company Secretary / Compliance Officer : Shivkant Dhakad